NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

Conditions:   Borderline Resectable Pancreatic Adenocarcinoma;   Locally Advanced Pancreatic Ductal Adenocarcinoma;   Resectable Pancreatic Ductal Adenocarcinoma;   Stage III Pancreatic Cancer AJCC v8 Interventions:   Other: Hafnium Oxide-containing Nanoparticles NBTXR3;   Radiation: Radiation Therapy Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials